Abstract
Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 967-981 |
| Number of pages | 15 |
| Journal | The Lancet Neurology |
| Volume | 15 |
| Issue number | 9 |
| DOIs | |
| State | Published - Aug 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Atypical inflammatory demyelinating syndromes of the CNS. / Hardy, Todd A.; Reddel, Stephen W.; Barnett, Michael H.; Palace, Jacqueline; Lucchinetti, Claudia F; Weinshenker, Brian G.
In: The Lancet Neurology, Vol. 15, No. 9, 01.08.2016, p. 967-981.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Atypical inflammatory demyelinating syndromes of the CNS
AU - Hardy, Todd A.
AU - Reddel, Stephen W.
AU - Barnett, Michael H.
AU - Palace, Jacqueline
AU - Lucchinetti, Claudia F
AU - Weinshenker, Brian G
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.
AB - Atypical inflammatory demyelinating syndromes are rare disorders that differ from multiple sclerosis owing to unusual clinical or MRI findings or poor response to treatments used for multiple sclerosis. These syndromes include neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis, tumefactive demyelination, Baló's concentric sclerosis, Schilder's disease, and Marburg's multiple sclerosis. The overlapping features of these syndromes with multiple sclerosis and with each other complicate diagnosis and their categorisation as distinct or related conditions. Recognition of these syndromes is crucial because they differ from multiple sclerosis and other demyelinating and non-demyelinating conditions in their prognosis and treatment. Advances in MRI, pathology, and immunobiology are needed to increase understanding of these syndromes, including the extent to which some of them represent distinct entities, and to assist with improvements in their diagnosis and management.
UR - http://www.scopus.com/inward/record.url?scp=84992184044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992184044&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(16)30043-6
DO - 10.1016/S1474-4422(16)30043-6
M3 - Review article
VL - 15
SP - 967
EP - 981
JO - The Lancet Neurology
JF - The Lancet Neurology
SN - 1474-4422
IS - 9
ER -